Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
France to build new nuclear aircraft carrier, Macron says - 2This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- 3Creative Style: 10 Architects Reclassifying the Business
- 45 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- 5Closets for Your Room: Plan and Utility Features
- Warning for snow and ice extended
- 5 VIPs That Changed Style
- The Best Internet based Courses for Expertise Improvement
- Over 60 local leaders push Netanyahu to halt haredi draft bill, warn of social rift
- Manual for Financial plan Agreeable PC
- Our 10 favorite Space.com reader astronomy photos of 2025
- Overlooked infertility care should be part of national health services, says WHO
- The most effective method to Plan an Incineration Administration: A Bit by bit Guide.
- Addressing sleep apnea early might decrease chances of developing Parkinson's disease
